Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box?
Animals
Chemoradiotherapy
/ adverse effects
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Disease Models, Animal
Granulocyte Colony-Stimulating Factor
/ adverse effects
Granulocyte-Macrophage Colony-Stimulating Factor
/ adverse effects
Humans
Lung Neoplasms
/ therapy
Mice
Radioimmunotherapy
/ adverse effects
Randomized Controlled Trials as Topic
Small Cell Lung Carcinoma
/ therapy
Journal
The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125
Informations de publication
Date de publication:
01 May 2020
01 May 2020
Historique:
pubmed:
24
1
2020
medline:
28
4
2020
entrez:
24
1
2020
Statut:
ppublish
Résumé
Concerns have been raised about potential toxic interactions when colony-stimulating factors (CSFs) and chemoradiation are concurrently performed. In 2006, the ASCO guidelines advised against their concomitant use. Nevertheless, with the development of modern radiotherapy techniques and supportive care, the therapeutic index of combined chemotherapy, radiotherapy, and CSFs is worth reassessing. Recent clinical trials testing chemoradiation in lung cancer let investigators free to decide the use of concomitant CSFs or not. No abnormal infield event was reported after the use of modern radiotherapy techniques and concomitant chemotherapy regimens. These elements call for further investigation to set new recommendations in favour of the association of chemoradiation and CSFs. Moreover, radiotherapy could induce anticancer systemic effects mediated by the immune system
Identifiants
pubmed: 31971824
doi: 10.1259/bjr.20190147
pmc: PMC7217575
doi:
Substances chimiques
Granulocyte Colony-Stimulating Factor
143011-72-7
Granulocyte-Macrophage Colony-Stimulating Factor
83869-56-1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
20190147Références
Blood. 1970 Jan;35(1):56-60
pubmed: 5412675
Clin Cancer Res. 2008 Aug 1;14(15):4883-90
pubmed: 18676762
Lancet Oncol. 2017 Feb;18(2):212-220
pubmed: 28081914
J Clin Oncol. 2010 May 1;28(13):2181-90
pubmed: 20351327
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818816076
pubmed: 31122176
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35
pubmed: 21093169
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):843-7
pubmed: 9652847
Anticancer Res. 1996 Mar-Apr;16(2):557-63
pubmed: 8687098
Oncologist. 2007 Jul;12(7):864-72
pubmed: 17673617
Curr Oncol. 2018 Oct;25(5):e454-e460
pubmed: 30464697
J Clin Oncol. 2015 Apr 20;33(12):1325-33
pubmed: 25584002
N Engl J Med. 1992 Jul 2;327(1):28-35
pubmed: 1375975
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
Cureus. 2019 Mar 19;11(3):e4276
pubmed: 31157137
Lancet Oncol. 2017 Aug;18(8):1116-1125
pubmed: 28642008
Eur J Med Res. 2006 Aug 30;11(8):322-8
pubmed: 17052967
Br J Haematol. 2000 Mar;108(4):848-53
pubmed: 10792294
Cancer. 2009 Aug 15;115(16):3670-9
pubmed: 19536890
J Clin Oncol. 2006 Jul 1;24(19):3187-205
pubmed: 16682719
Hum Vaccin Immunother. 2016 Dec;12(12):3020-3028
pubmed: 27560197
J Cancer Res Ther. 2017;13(5):790-795
pubmed: 29237905
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
JAMA. 2014 Nov 5;312(17):1744-53
pubmed: 25369488
Balkan Med J. 2014 Dec;31(4):286-94
pubmed: 25667781
Cancer Res. 2013 Nov 1;73(21):6413-23
pubmed: 24030977
Immunotherapy. 2018 Feb 1;10(4):299-316
pubmed: 29421979
Blood. 1980 Dec;56(6):947-58
pubmed: 7002232
Cancer. 2004 Jan 15;100(2):228-37
pubmed: 14716755
Oncology (Williston Park). 2005 Apr;19(4 Suppl 2):5-9
pubmed: 15934493
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11300-11305
pubmed: 27651484
Cancer Res. 1999 Oct 15;59(20):5160-8
pubmed: 10537292
Oral Oncol. 2017 Oct;73:138-146
pubmed: 28939066
Gynecol Oncol. 2010 Mar;116(3):438-41
pubmed: 19896180
Bone. 2014 Jun;63:87-94
pubmed: 24607941
Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):469-78
pubmed: 9806503
Oncol Lett. 2013 May;5(5):1736-1740
pubmed: 23760066
Pharmacotherapy. 2000 Dec;20(12):1432-40
pubmed: 11130215
Sci Immunol. 2016 Sep;1(3):
pubmed: 28018989
Lung Cancer. 2011 Oct;74(1):75-9
pubmed: 21353720
Oncologist. 2010;15(2):187-95
pubmed: 20145192
Radiat Oncol. 2015 Aug 04;10:162
pubmed: 26238572
Lancet Oncol. 2011 Feb;12(2):127-36
pubmed: 21236730
Cytokine. 2015 Oct;75(2):261-71
pubmed: 26113402
JAMA Oncol. 2015 Dec;1(9):1325-32
pubmed: 26270858
Nature. 2014 Nov 27;515(7528):563-7
pubmed: 25428504
J Immunol. 2015 Aug 15;195(4):1341-9
pubmed: 26254266
Am J Clin Oncol. 2012 Jun;35(3):267-74
pubmed: 21378538
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):83-90
pubmed: 23582248
J Intern Med. 2016 Jun;279(6):541-62
pubmed: 26748421
Blood. 2012 Apr 12;119(15):3383-93
pubmed: 22323450
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):563-70
pubmed: 27020104
Lancet Oncol. 2015 Jul;16(7):795-803
pubmed: 26095785
J Interferon Cytokine Res. 2015 Aug;35(8):585-99
pubmed: 25803788
J Clin Oncol. 1995 Jul;13(7):1632-41
pubmed: 7602352
J Hematol Oncol. 2018 Aug 16;11(1):104
pubmed: 30115069
Cancer Biol Ther. 2017 Mar 4;18(3):137-141
pubmed: 28267380
Radiat Oncol. 2014 Jan 10;9:17
pubmed: 24410971
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1081-7
pubmed: 17398031
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Infection. 1992;20 Suppl 2:S124-7
pubmed: 1493936
Radiother Oncol. 2003 Sep;68(3):217-26
pubmed: 13129628
Blood. 1991 Dec 1;78(11):2791-808
pubmed: 1720034
J Clin Oncol. 1994 Oct;12(10):2022-34
pubmed: 7931470
Drugs Today (Barc). 2018 Nov;54(11):679-693
pubmed: 30539167
Clin Transl Oncol. 2017 Jan;19(1):67-75
pubmed: 27037814
J Leukoc Biol. 2016 Sep;100(3):481-9
pubmed: 27354413
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407